UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Understanding when and how to adjust a zero based budget helps you stay aligned with goals. Explore timing, methods, and best practices.
28,655 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
Huntington & Ellis launches Smart by h&e, an in-house AI assistant designed to streamline deals, draft communications...
Traders are watching Ripple’s payments push and regulatory tones as an AI model’s no-guardrails forecast for XRP by 2...
SoftBank announces a sweeping €75 billion plan to build up to 5 GW of AI data center capacity in France, with an init...
Regulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...
Poet Technologies faces a pivotal year as AI-driven optical interconnects scale. This report analyzes catalysts, risk...
A divorced listener earning about $100,000 was advised to liquidate home equity to wipe out debt, a move that reignit...
Apple files a federal trade secret suit against OpenAI, arguing a pattern of theft to protect its hardware lead. The ...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
As the 10-year Treasury sits in the low- to mid-4% zone, select dividend stocks more than keep pace with bond returns...
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...